Eli Lilly & Co. (LLY) Tops Q4 EPS by 18c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,273.46 -2.54%
Revenue Growth %: +27.4%
Financial Fact:
Income taxes: 192.7M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Revenue Growth %: +27.4%
Financial Fact:
Income taxes: 192.7M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q4 EPS of $2.49, $0.18 better than the analyst estimate of $2.31. Revenue for the quarter came in at $9.35 billion versus the consensus estimate of $8.95 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2024 EPS of $12.20-$12.70, versus the consensus of $12.38. Eli Lilly & Co. sees FY2024 revenue of $40.4-41.6 billion, versus the consensus of $39.138 billion.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- New data on Lilly's investigational treatment olomorasib at ESMO 2026 show durable first-line activity in KRAS G12C-mutant non-small cell lung cancer
- Eli Lilly & Co. (LLY) call put ratio 1 call to 1 put into quarter results
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
